Use of Duloxetine for Perioperative Pain Control After Total Hip Arthroplasty: Randomized Controlled Clinical Trial (RCT)

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients \> 18 years of age

• Patients undergoing primary total hip arthroplasty

• Ambulatory patient prior to fracture

• Subjects must be capable of providing informed consent

• English or Spanish speaking

Locations
United States
Florida
University of Miami
RECRUITING
Miami
Contact Information
Primary
Victor Hernandez, MD
vhh1@miami.edu
3056895195
Backup
Natalia Cruz, MD
nxc971@miami.edu
3056895195
Time Frame
Start Date: 2025-03-01
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 64
Treatments
Experimental: Duloxetine group
Participants will be in this group for up to 2 hours.
Placebo_comparator: Placebo group
Participants will be in this group for up to 2 hours.
Related Therapeutic Areas
Sponsors
Leads: University of Miami

This content was sourced from clinicaltrials.gov